05:57 PM EDT, 07/09/2024 (MT Newswires) -- Trinity Biotech ( TRIB ) late Tuesday was adding to its regular-session gain after saying it has selected UDG to be the permanent chief financial officer, succeeding Des Fitzgerald.

Tallon is slated to join Trinity next month from Inizio, a pharmaceuticals commercialization services firm, since 2021 following a 16-year career at UDG Healthcare.

Trinity Biotech ( TRIB ) shares were climbing 4.5%, adding to a nearly 20% regular-session advance.

Price: 2.5400, Change: +0.11, Percent Change: +4.53